Bidil and Ambien drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bidil (hydralazine hydrochloride; isosorbide dinitrate) and Ambien (zolpidem tartrate). Common drug interactions include hiatus hernia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Bidil and Ambien. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Bidil?

Bidil has active ingredients of hydralazine hydrochloride; isosorbide dinitrate. eHealthMe is studying from 520 Bidil users. Check the latest studies of Bidil.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 93,519 Ambien users. Check the latest studies of Ambien.



On Jul, 11, 2026

13 people who take Bidil and Ambien together, and have interactions are studied.

Bidil and Ambien drug interactions.

What are the common drug interactions of Bidil and Ambien, by gender? *:

female:

  1. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  2. Hydronephrosis (water inside the kidney)
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  4. Hypercholesterolaemia (high levels of cholesterol in the blood)
  5. Hypertension (high blood pressure)
  6. Hypotension (abnormally low blood pressure)
  7. Ill-defined disorder
  8. Injury
  9. Left ventricular dysfunction
  10. Malaise (a feeling of general discomfort or uneasiness)

male:

  1. Chronic kidney disease
  2. Abdominal distension
  3. Blood glucose decreased
  4. Blood pressure decreased
  5. Bradycardia (abnormally slow heart action)
  6. Cardiac failure congestive
  7. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  8. Central obesity (belly fat)
  9. Chest pain
  10. Chills (felling of cold)

What are the common drug interactions of Bidil and Ambien, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal distension
  2. Abdominal pain upper
  3. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  4. Constipation
  5. Diarrhoea
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Hypotension (abnormally low blood pressure)
  8. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  9. Nausea (feeling of having an urge to vomit)
  10. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Frequent bowel movements
  2. Hyperphagia (an abnormal appetite for food)
  3. Muscle spasms (muscle contraction)
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Atelectasis (partial or complete collapse of the lung)
  6. Blood cholesterol increased
  7. Blood magnesium decreased
  8. Blood uric acid increased
  9. Calculus ureteric (stone in ureter)
  10. Cardiac failure congestive

60+:

  1. Blood potassium decreased
  2. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

  1. Pain: 4 people, 30.77%
  2. High Blood Cholesterol: 3 people, 23.08%
  3. Cardiac Disorder: 3 people, 23.08%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
  5. High Blood Pressure: 2 people, 15.38%
  6. Cardiac Failure Congestive: 2 people, 15.38%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 15.38%
  8. Depression: 2 people, 15.38%
  9. Dizziness: 2 people, 15.38%
  10. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Bidil and Ambien?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bidil and Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ambien and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydralazine hydrochloride; isosorbide dinitrate and zolpidem tartrate (the active ingredients of Bidil and Ambien, respectively), and Bidil and Ambien (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: